Moderna advances global health commitment with mRNA vaccine candidate against the Nipah virus, a lethal pathogen with pandemic potential. Moderna, Inc., a biotechnology company pioneering messenger...
This mRNA vaccine successfully prevented the development of Lyme disease in guinea pigs after tick bite and removal. Caused by the bacterium B. burgdorferi and more rarely, B. mayonii, Lyme...
Planned state-of-the-art manufacturing site by BioNTech will support global supply of mRNA-based vaccines and therapeutics and provide a rapid response capability for Southeast Asia against potential...
mRNA-based vaccine candidate developed by Pfizer and BioNTech demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of infection, according to first interim...
Using STARR technology™ platform developed by Arcturus Therapeutics, Duke-NUS Medical School hopes to conduct rapid screening of vaccines for effectiveness and safety. COVID-19 is caused by the...
In the continuing series on the COVID-19 outbreak, APBN takes a closer look at coronaviruses to help readers better understand the feverish pace of work undertaken by researchers and scientists in...
Offers opportunities in developing therapies for this disease. A new discovery has unearthed a group of small regulatory RNAs, known as the mir-17~92 cluster, that protects motor neurons, a cell type...
